SBC's occupier, Exploristics, has launched the Spring 2021 release of their clinical trial simulation software, KerusCloud.
Based on ongoing development and extensive user feedback, this new release includes a range of transformational new features with a view to smarter clinical study design and analysis approaches using simulation.
To help new and future users learn more about how KerusCloud 2021 can drive more successful clinical development, they have scheduled a series of free live introductory webinars hosted by Exploristics’ CEO, Aiden Flynn.
Contact Exploristics for more information.
Copyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.